CA Stock MarketDetailed Quotes

Johnson & Johnson CDR (CAD Hedged) (JNJ)

Watchlist
  • 29.280
  • -0.350-1.18%
15min DelayMarket Closed May 1 16:00 ET
725.01BMarket Cap25.11P/E (TTM)

Johnson & Johnson CDR (CAD Hedged) (JNJ) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 29, 2026
(FY)Dec 28, 2025
(Q4)Dec 28, 2025
(Q3)Sep 28, 2025
(Q2)Jun 29, 2025
(Q1)Mar 30, 2025
(FY)Dec 29, 2024
(Q4)Dec 29, 2024
(Q3)Sep 29, 2024
(Q2)Jun 30, 2024
Total revenue
9.91%24.06B
6.05%94.19B
9.08%24.56B
6.77%23.99B
5.77%23.74B
2.39%21.89B
4.30%88.82B
5.26%22.52B
5.25%22.47B
4.31%22.45B
Operating revenue
9.91%24.06B
6.05%94.19B
9.08%24.56B
6.77%23.99B
5.77%23.74B
2.39%21.89B
4.30%88.82B
5.26%22.52B
5.25%22.47B
4.31%22.45B
Cost of revenue
10.18%8.11B
10.14%30.26B
11.78%7.97B
4.88%7.3B
11.05%7.63B
12.99%7.36B
3.46%27.47B
4.85%7.13B
5.40%6.96B
6.30%6.87B
Gross profit
9.77%15.96B
4.22%63.94B
7.82%16.6B
7.62%16.69B
3.45%16.12B
-2.26%14.54B
4.68%61.35B
5.45%15.39B
5.17%15.51B
3.46%15.58B
Operating expense
14.68%9.56B
-4.39%38.34B
-6.35%11.01B
-8.02%9.59B
3.11%9.41B
-5.25%8.34B
9.57%40.1B
14.20%11.75B
17.89%10.43B
0.24%9.12B
Selling and administrative expenses
18.04%6.03B
3.53%23.68B
4.65%6.75B
8.11%5.92B
3.66%5.89B
-2.76%5.11B
6.31%22.87B
11.07%6.45B
1.44%5.48B
5.28%5.68B
-General and administrative expense
----
----
----
8.11%5.92B
3.66%5.89B
-2.76%5.11B
6.31%22.87B
11.07%6.45B
1.44%5.48B
5.28%5.68B
Research and development costs
9.36%3.53B
-14.90%14.67B
-19.74%4.25B
-25.85%3.67B
2.21%3.52B
-8.95%3.23B
14.23%17.23B
18.26%5.3B
43.66%4.95B
-7.10%3.44B
Operating profit
3.16%6.4B
20.46%25.6B
53.56%5.59B
39.74%7.1B
3.92%6.71B
2.07%6.2B
-3.45%21.25B
-15.46%3.64B
-13.90%5.08B
8.38%6.46B
Net non-operating interest income (expenses)
-133.59%-43M
-85.27%85M
-84.03%23M
-118.18%-18M
-138.40%-48M
-38.76%128M
18.00%577M
-32.08%144M
-45.60%99M
14.68%125M
Non-operating interest income
-31.02%229M
-20.72%1.06B
-15.66%237M
-22.26%227M
-34.18%260M
-8.79%332M
5.63%1.33B
-22.59%281M
-21.93%292M
21.17%395M
Non-operating interest expense
33.33%272M
28.61%971M
56.20%214M
26.94%245M
14.07%308M
31.61%204M
-2.20%755M
-9.27%137M
0.52%193M
24.42%270M
Other net income (expenses)
-104.96%-362M
233.94%6.89B
-571.63%-665M
123.74%437M
81.38%-164M
384.42%7.3B
30.81%-5.15B
-46.18%141M
-113.08%-1.84B
-445.49%-881M
Gain on sale of security
----
233.33%400M
0.00%100M
--400M
----
----
50.00%-300M
-80.00%100M
----
---400M
Special income (charges)
-106.80%-468M
181.41%5.49B
-444.03%-865M
93.59%-163M
57.08%-464M
332.22%6.88B
-741.02%-6.75B
-102.27%-159M
-862.50%-2.54B
-341.22%-1.08B
-Less:Restructuring and mergern&acquisition
12.82%132M
-58.61%428M
-181.69%-116M
15.60%163M
-57.62%164M
-55.68%117M
111.45%1.03B
208.70%142M
-10.76%141M
166.90%387M
-Less:Impairment of capital assets
----
-61.61%81M
----
----
----
----
-32.59%211M
----
----
----
-Less:Other special charges
104.29%300M
-209.09%-6B
--900M
----
-40.00%300M
-359.26%-7B
-24.66%5.5B
--0
2,500.00%2.4B
400.00%500M
-Less:Write off
--36M
----
----
----
--0
--0
----
----
--0
--194M
Other non-operating income (expenses)
-74.82%106M
-47.37%1B
-50.00%100M
-71.43%200M
-50.00%300M
6.31%421M
128.64%1.9B
102.55%200M
75.00%700M
20.00%600M
Income before tax
-56.06%5.99B
95.25%32.58B
27.76%4.97B
124.48%7.49B
12.93%6.49B
267.02%13.63B
10.79%16.69B
-19.46%3.89B
-36.02%3.34B
-8.85%5.75B
Income tax
-71.31%755M
120.41%5.78B
-132.89%-150M
263.51%2.34B
-10.17%954M
473.42%2.63B
50.98%2.62B
-34.29%456M
-29.07%644M
14.19%1.06B
Earnings from equity interest net of tax
Net income
-52.40%5.24B
90.56%26.8B
49.11%5.12B
91.24%5.15B
18.16%5.54B
237.91%11B
-59.99%14.07B
-15.26%3.43B
-89.65%2.69B
-8.90%4.69B
Net income continuous operations
-52.40%5.24B
90.56%26.8B
49.11%5.12B
91.24%5.15B
18.16%5.54B
237.91%11B
5.55%14.07B
-16.97%3.43B
-37.48%2.69B
-12.83%4.69B
Net income discontinuous operations
----
--0
----
----
----
----
--0
--0
--0
--0
Noncontrolling interests
Net income attributable to the company
-52.40%5.24B
90.56%26.8B
49.11%5.12B
91.24%5.15B
18.16%5.54B
237.91%11B
-59.99%14.07B
-15.26%3.43B
-89.65%2.69B
-8.90%4.69B
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-52.40%5.24B
90.56%26.8B
49.11%5.12B
91.24%5.15B
18.16%5.54B
237.91%11B
-59.99%14.07B
-15.26%3.43B
-89.65%2.69B
-8.90%4.69B
Diluted earnings per share
-52.52%0.211
90.58%1.082
49.05%0.2066
91.07%0.208
17.95%0.2236
238.52%0.4443
-57.93%0.5677
-15.25%0.1386
-89.15%0.1089
-1.51%0.1896
Basic earnings per share
-52.86%0.208
90.50%1.0723
48.94%0.2042
90.99%0.2061
18.65%0.2226
238.81%0.4414
-57.80%0.5629
-15.57%0.1371
-89.13%0.1079
-1.53%0.1876
Dividend per share
5.44%0.1213
-0.34%0.4783
-0.54%0.1175
-0.16%0.1227
1.77%0.1231
-2.51%0.115
314.33%0.48
1.98%0.1181
0.1229
0.121
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 29, 2026(FY)Dec 28, 2025(Q4)Dec 28, 2025(Q3)Sep 28, 2025(Q2)Jun 29, 2025(Q1)Mar 30, 2025(FY)Dec 29, 2024(Q4)Dec 29, 2024(Q3)Sep 29, 2024(Q2)Jun 30, 2024
Total revenue 9.91%24.06B6.05%94.19B9.08%24.56B6.77%23.99B5.77%23.74B2.39%21.89B4.30%88.82B5.26%22.52B5.25%22.47B4.31%22.45B
Operating revenue 9.91%24.06B6.05%94.19B9.08%24.56B6.77%23.99B5.77%23.74B2.39%21.89B4.30%88.82B5.26%22.52B5.25%22.47B4.31%22.45B
Cost of revenue 10.18%8.11B10.14%30.26B11.78%7.97B4.88%7.3B11.05%7.63B12.99%7.36B3.46%27.47B4.85%7.13B5.40%6.96B6.30%6.87B
Gross profit 9.77%15.96B4.22%63.94B7.82%16.6B7.62%16.69B3.45%16.12B-2.26%14.54B4.68%61.35B5.45%15.39B5.17%15.51B3.46%15.58B
Operating expense 14.68%9.56B-4.39%38.34B-6.35%11.01B-8.02%9.59B3.11%9.41B-5.25%8.34B9.57%40.1B14.20%11.75B17.89%10.43B0.24%9.12B
Selling and administrative expenses 18.04%6.03B3.53%23.68B4.65%6.75B8.11%5.92B3.66%5.89B-2.76%5.11B6.31%22.87B11.07%6.45B1.44%5.48B5.28%5.68B
-General and administrative expense ------------8.11%5.92B3.66%5.89B-2.76%5.11B6.31%22.87B11.07%6.45B1.44%5.48B5.28%5.68B
Research and development costs 9.36%3.53B-14.90%14.67B-19.74%4.25B-25.85%3.67B2.21%3.52B-8.95%3.23B14.23%17.23B18.26%5.3B43.66%4.95B-7.10%3.44B
Operating profit 3.16%6.4B20.46%25.6B53.56%5.59B39.74%7.1B3.92%6.71B2.07%6.2B-3.45%21.25B-15.46%3.64B-13.90%5.08B8.38%6.46B
Net non-operating interest income (expenses) -133.59%-43M-85.27%85M-84.03%23M-118.18%-18M-138.40%-48M-38.76%128M18.00%577M-32.08%144M-45.60%99M14.68%125M
Non-operating interest income -31.02%229M-20.72%1.06B-15.66%237M-22.26%227M-34.18%260M-8.79%332M5.63%1.33B-22.59%281M-21.93%292M21.17%395M
Non-operating interest expense 33.33%272M28.61%971M56.20%214M26.94%245M14.07%308M31.61%204M-2.20%755M-9.27%137M0.52%193M24.42%270M
Other net income (expenses) -104.96%-362M233.94%6.89B-571.63%-665M123.74%437M81.38%-164M384.42%7.3B30.81%-5.15B-46.18%141M-113.08%-1.84B-445.49%-881M
Gain on sale of security ----233.33%400M0.00%100M--400M--------50.00%-300M-80.00%100M-------400M
Special income (charges) -106.80%-468M181.41%5.49B-444.03%-865M93.59%-163M57.08%-464M332.22%6.88B-741.02%-6.75B-102.27%-159M-862.50%-2.54B-341.22%-1.08B
-Less:Restructuring and mergern&acquisition 12.82%132M-58.61%428M-181.69%-116M15.60%163M-57.62%164M-55.68%117M111.45%1.03B208.70%142M-10.76%141M166.90%387M
-Less:Impairment of capital assets -----61.61%81M-----------------32.59%211M------------
-Less:Other special charges 104.29%300M-209.09%-6B--900M-----40.00%300M-359.26%-7B-24.66%5.5B--02,500.00%2.4B400.00%500M
-Less:Write off --36M--------------0--0----------0--194M
Other non-operating income (expenses) -74.82%106M-47.37%1B-50.00%100M-71.43%200M-50.00%300M6.31%421M128.64%1.9B102.55%200M75.00%700M20.00%600M
Income before tax -56.06%5.99B95.25%32.58B27.76%4.97B124.48%7.49B12.93%6.49B267.02%13.63B10.79%16.69B-19.46%3.89B-36.02%3.34B-8.85%5.75B
Income tax -71.31%755M120.41%5.78B-132.89%-150M263.51%2.34B-10.17%954M473.42%2.63B50.98%2.62B-34.29%456M-29.07%644M14.19%1.06B
Earnings from equity interest net of tax
Net income -52.40%5.24B90.56%26.8B49.11%5.12B91.24%5.15B18.16%5.54B237.91%11B-59.99%14.07B-15.26%3.43B-89.65%2.69B-8.90%4.69B
Net income continuous operations -52.40%5.24B90.56%26.8B49.11%5.12B91.24%5.15B18.16%5.54B237.91%11B5.55%14.07B-16.97%3.43B-37.48%2.69B-12.83%4.69B
Net income discontinuous operations ------0------------------0--0--0--0
Noncontrolling interests
Net income attributable to the company -52.40%5.24B90.56%26.8B49.11%5.12B91.24%5.15B18.16%5.54B237.91%11B-59.99%14.07B-15.26%3.43B-89.65%2.69B-8.90%4.69B
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -52.40%5.24B90.56%26.8B49.11%5.12B91.24%5.15B18.16%5.54B237.91%11B-59.99%14.07B-15.26%3.43B-89.65%2.69B-8.90%4.69B
Diluted earnings per share -52.52%0.21190.58%1.08249.05%0.206691.07%0.20817.95%0.2236238.52%0.4443-57.93%0.5677-15.25%0.1386-89.15%0.1089-1.51%0.1896
Basic earnings per share -52.86%0.20890.50%1.072348.94%0.204290.99%0.206118.65%0.2226238.81%0.4414-57.80%0.5629-15.57%0.1371-89.13%0.1079-1.53%0.1876
Dividend per share 5.44%0.1213-0.34%0.4783-0.54%0.1175-0.16%0.12271.77%0.1231-2.51%0.115314.33%0.481.98%0.11810.12290.121
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More